Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

230 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis.
Monzon FA, Alvarez K, Peterson L, Truong L, Amato RJ, Hernandez-McClain J, Tannir N, Parwani AV, Jonasch E. Monzon FA, et al. Mod Pathol. 2011 Nov;24(11):1470-9. doi: 10.1038/modpathol.2011.107. Epub 2011 Jul 1. Mod Pathol. 2011. PMID: 21725288 Free PMC article. Clinical Trial.
Role of radiation therapy in the management of renal cell cancer.
Blanco AI, Teh BS, Amato RJ. Blanco AI, et al. Cancers (Basel). 2011 Oct 26;3(4):4010-23. doi: 10.3390/cancers3044010. Cancers (Basel). 2011. PMID: 24213122 Free PMC article.
A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases.
Jhaveri PM, Teh BS, Paulino AC, Blanco AI, Lo SS, Butler EB, Amato RJ. Jhaveri PM, et al. Acta Oncol. 2012 May;51(5):584-8. doi: 10.3109/0284186X.2011.652741. Epub 2012 Jan 17. Acta Oncol. 2012. PMID: 22248089
Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study.
Amato RJ, Hawkins RE, Kaufman HL, Thompson JA, Tomczak P, Szczylik C, McDonald M, Eastty S, Shingler WH, de Belin J, Goonewardena M, Naylor S, Harrop R. Amato RJ, et al. Clin Cancer Res. 2010 Nov 15;16(22):5539-47. doi: 10.1158/1078-0432.CCR-10-2082. Epub 2010 Sep 29. Clin Cancer Res. 2010. PMID: 20881001 Clinical Trial.
Current immunotherapeutic strategies in renal cell carcinoma.
Amato RJ. Amato RJ. Surg Oncol Clin N Am. 2007 Oct;16(4):975-86, xi-xii. doi: 10.1016/j.soc.2007.07.006. Surg Oncol Clin N Am. 2007. PMID: 18022554 Review.
Targeted anti-cancer therapies for renal cancer.
Amato RJ, Jac J. Amato RJ, et al. Drugs. 2006;66(17):2161-71. doi: 10.2165/00003495-200666170-00002. Drugs. 2006. PMID: 17137401 Review.
Metastatic renal cell carcinoma to the nose and ethmoid sinus.
Ziari M, Shen S, Amato RJ, Teh BS. Ziari M, et al. Urology. 2006 Jan;67(1):199. doi: 10.1016/j.urology.2005.07.052. Urology. 2006. PMID: 16413368
A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma.
Amato RJ, Khan M. Amato RJ, et al. Cancer Chemother Pharmacol. 2008 May;61(6):1069-73. doi: 10.1007/s00280-007-0568-7. Epub 2007 Aug 14. Cancer Chemother Pharmacol. 2008. PMID: 17701037 Clinical Trial.
230 results
Jump to page
Feedback